

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.17469537 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.17469537 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.17469537 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.17469537 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.17469537 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.17469537 |
| 7 | response to peptidoglycan (GO:0032494) | 4.87908473 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.84808395 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.84808395 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.75781138 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.74297058 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.69654970 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.64913464 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.62240427 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.57537133 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.20520914 |
| 17 | detection of other organism (GO:0098543) | 4.17711279 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.17240129 |
| 19 | cellular extravasation (GO:0045123) | 4.14821737 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.95529561 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91118416 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85527194 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.83531701 |
| 24 | L-phenylalanine catabolic process (GO:0006559) | 3.82912455 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82912455 |
| 26 | neutrophil activation (GO:0042119) | 3.82030505 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81912801 |
| 28 | detection of bacterium (GO:0016045) | 3.78171612 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.74786615 |
| 30 | granulocyte activation (GO:0036230) | 3.72268723 |
| 31 | protein carboxylation (GO:0018214) | 3.65371497 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.65371497 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.64480716 |
| 34 | urea metabolic process (GO:0019627) | 3.63973932 |
| 35 | urea cycle (GO:0000050) | 3.63973932 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.63628093 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61352884 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60893162 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.60893162 |
| 40 | regulation of protein activation cascade (GO:2000257) | 3.60887546 |
| 41 | macrophage activation (GO:0042116) | 3.58736382 |
| 42 | microglial cell activation (GO:0001774) | 3.56311976 |
| 43 | lysine catabolic process (GO:0006554) | 3.52745958 |
| 44 | lysine metabolic process (GO:0006553) | 3.52745958 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51348509 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49117861 |
| 47 | regulation of complement activation (GO:0030449) | 3.48177464 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.47986799 |
| 49 | response to host immune response (GO:0052572) | 3.47986799 |
| 50 | leukocyte aggregation (GO:0070486) | 3.47580950 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47302634 |
| 52 | detection of biotic stimulus (GO:0009595) | 3.47286781 |
| 53 | reverse cholesterol transport (GO:0043691) | 3.40540533 |
| 54 | phospholipid efflux (GO:0033700) | 3.40430349 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.38498279 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.36418141 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 3.36198053 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 3.35297322 |
| 59 | phospholipid homeostasis (GO:0055091) | 3.34620947 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.34275482 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.32647097 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32510356 |
| 63 | response to host (GO:0075136) | 3.32510356 |
| 64 | response to host defenses (GO:0052200) | 3.32510356 |
| 65 | neutrophil mediated immunity (GO:0002446) | 3.28941761 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26355818 |
| 67 | germinal center formation (GO:0002467) | 3.26075425 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23870726 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 3.22226102 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18186995 |
| 71 | nitrogen cycle metabolic process (GO:0071941) | 3.17935344 |
| 72 | bile acid biosynthetic process (GO:0006699) | 3.17848818 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.15208317 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.15208317 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 3.14007248 |
| 76 | negative regulation of sterol transport (GO:0032372) | 3.14007248 |
| 77 | response to type I interferon (GO:0034340) | 3.12571525 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.12216043 |
| 79 | respiratory burst (GO:0045730) | 3.11942982 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 3.11400070 |
| 81 | kynurenine metabolic process (GO:0070189) | 3.09832695 |
| 82 | regulation of mast cell activation (GO:0033003) | 3.09652740 |
| 83 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09320689 |
| 84 | cholesterol efflux (GO:0033344) | 3.08834978 |
| 85 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08725576 |
| 86 | sulfur amino acid catabolic process (GO:0000098) | 3.08228341 |
| 87 | regulation of fibrinolysis (GO:0051917) | 3.07271736 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05575390 |
| 89 | triglyceride homeostasis (GO:0070328) | 3.05232432 |
| 90 | acylglycerol homeostasis (GO:0055090) | 3.05232432 |
| 91 | hemidesmosome assembly (GO:0031581) | 3.05066832 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.04068338 |
| 93 | T-helper 1 type immune response (GO:0042088) | 3.03876796 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.02997614 |
| 95 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.02583647 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.02206055 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.00966396 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00861211 |
| 99 | regulation of leukocyte degranulation (GO:0043300) | 3.00794525 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.99915824 |
| 101 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97475131 |
| 102 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97335037 |
| 103 | response to interleukin-15 (GO:0070672) | 2.97274022 |
| 104 | indole-containing compound catabolic process (GO:0042436) | 2.95878684 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 2.95878684 |
| 106 | tryptophan catabolic process (GO:0006569) | 2.95878684 |
| 107 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95787545 |
| 108 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95080305 |
| 109 | glyoxylate metabolic process (GO:0046487) | 2.94163783 |
| 110 | regulation of interferon-alpha production (GO:0032647) | 2.93203968 |
| 111 | bile acid and bile salt transport (GO:0015721) | 2.92679362 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.92644993 |
| 113 | defense response to protozoan (GO:0042832) | 2.92370730 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.91828890 |
| 115 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91355969 |
| 116 | plasma lipoprotein particle remodeling (GO:0034369) | 2.91066331 |
| 117 | protein-lipid complex remodeling (GO:0034368) | 2.91066331 |
| 118 | macromolecular complex remodeling (GO:0034367) | 2.91066331 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.90278363 |
| 120 | bile acid metabolic process (GO:0008206) | 2.90240270 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 2.90170830 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.89715909 |
| 123 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.89715909 |
| 124 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87715426 |
| 125 | drug catabolic process (GO:0042737) | 2.86688538 |
| 126 | cholesterol homeostasis (GO:0042632) | 2.84755726 |
| 127 | neutrophil chemotaxis (GO:0030593) | 2.84285276 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83937614 |
| 129 | tryptophan metabolic process (GO:0006568) | 2.83250024 |
| 130 | regulation of T cell tolerance induction (GO:0002664) | 2.83093759 |
| 131 | B cell mediated immunity (GO:0019724) | 2.82232720 |
| 132 | regulation of cholesterol esterification (GO:0010872) | 2.82161252 |
| 133 | sterol homeostasis (GO:0055092) | 2.82115458 |
| 134 | apoptotic cell clearance (GO:0043277) | 2.81899244 |
| 135 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81359735 |
| 136 | myeloid leukocyte activation (GO:0002274) | 2.81030692 |
| 137 | regulation of bile acid biosynthetic process (GO:0070857) | 2.80729885 |
| 138 | myeloid leukocyte mediated immunity (GO:0002444) | 2.80230731 |
| 139 | positive regulation of lipid catabolic process (GO:0050996) | 2.80119557 |
| 140 | lipoprotein metabolic process (GO:0042157) | 2.80103471 |
| 141 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79853457 |
| 142 | cysteine metabolic process (GO:0006534) | 2.78375913 |
| 143 | amino-acid betaine metabolic process (GO:0006577) | 2.77057745 |
| 144 | neutrophil migration (GO:1990266) | 2.76982537 |
| 145 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76192990 |
| 146 | cellular glucuronidation (GO:0052695) | 2.74880844 |
| 147 | response to protozoan (GO:0001562) | 2.73497281 |
| 148 | intestinal cholesterol absorption (GO:0030299) | 2.71882002 |
| 149 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71659239 |
| 150 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.71345917 |
| 151 | leukocyte degranulation (GO:0043299) | 2.71168140 |
| 152 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.69520222 |
| 153 | positive regulation of mast cell degranulation (GO:0043306) | 2.69442377 |
| 154 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69442377 |
| 155 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.66681494 |
| 156 | negative regulation of lipase activity (GO:0060192) | 2.66637835 |
| 157 | negative regulation of interleukin-6 production (GO:0032715) | 2.66515718 |
| 158 | fibrinolysis (GO:0042730) | 2.65328598 |
| 159 | homocysteine metabolic process (GO:0050667) | 2.64612721 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63597695 |
| 161 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63597695 |
| 162 | tolerance induction (GO:0002507) | 2.62701704 |
| 163 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.62682383 |
| 164 | complement activation (GO:0006956) | 2.62577399 |
| 165 | cellular response to interleukin-15 (GO:0071350) | 2.62311155 |
| 166 | positive regulation of interferon-beta production (GO:0032728) | 2.61285190 |
| 167 | positive regulation of type 2 immune response (GO:0002830) | 2.60901585 |
| 168 | hormone catabolic process (GO:0042447) | 2.59643067 |
| 169 | tooth mineralization (GO:0034505) | 2.59095803 |
| 170 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.58060094 |
| 171 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57712706 |
| 172 | complement activation, classical pathway (GO:0006958) | 2.54884270 |
| 173 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.54237918 |
| 174 | protein-lipid complex subunit organization (GO:0071825) | 2.47262956 |
| 175 | lipid homeostasis (GO:0055088) | 2.47236740 |
| 176 | ethanol oxidation (GO:0006069) | 2.46817289 |
| 177 | plasma lipoprotein particle organization (GO:0071827) | 2.45270687 |
| 178 | glutamate metabolic process (GO:0006536) | 2.44796557 |
| 179 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.43818320 |
| 180 | transcytosis (GO:0045056) | 2.43752358 |
| 181 | uronic acid metabolic process (GO:0006063) | 2.43629781 |
| 182 | glucuronate metabolic process (GO:0019585) | 2.43629781 |
| 183 | regulation of cholesterol storage (GO:0010885) | 2.41864028 |
| 184 | epoxygenase P450 pathway (GO:0019373) | 2.41412651 |
| 185 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.39431198 |
| 186 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.39431198 |
| 187 | tyrosine metabolic process (GO:0006570) | 2.38314940 |
| 188 | aspartate family amino acid catabolic process (GO:0009068) | 2.37376538 |
| 189 | 2-oxoglutarate metabolic process (GO:0006103) | 2.36882691 |
| 190 | positive regulation of hemostasis (GO:1900048) | 2.35449801 |
| 191 | positive regulation of blood coagulation (GO:0030194) | 2.35449801 |
| 192 | protein activation cascade (GO:0072376) | 2.35059800 |
| 193 | serine family amino acid catabolic process (GO:0009071) | 2.33228829 |
| 194 | negative regulation of protein activation cascade (GO:2000258) | 2.32635500 |
| 195 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.32114491 |
| 196 | cellular modified amino acid catabolic process (GO:0042219) | 2.31946627 |
| 197 | fatty acid beta-oxidation (GO:0006635) | 2.31941805 |
| 198 | growth hormone receptor signaling pathway (GO:0060396) | 2.31045576 |
| 199 | cholesterol transport (GO:0030301) | 2.30905515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.64818843 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17793559 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.80557327 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.75812169 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26496393 |
| 6 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.87333545 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81299086 |
| 8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80589213 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78247689 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63775830 |
| 11 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.54883329 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42034741 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34504316 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.34364386 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22314527 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09636776 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02626965 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01694323 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01405580 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96783433 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96576575 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95585619 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95194214 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91361264 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89458506 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.87821660 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87531269 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85042981 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83717313 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83424776 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79947620 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.79578494 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73514132 |
| 34 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69063757 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68485040 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62524557 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.60585261 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60372290 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.59233076 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57331077 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57216579 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55871173 |
| 43 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49190418 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47032151 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46954922 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46594817 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45947400 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44232246 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42853794 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42787288 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40758616 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39694699 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38911401 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38630717 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38176236 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37160585 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37029661 |
| 58 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35441723 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34925874 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34902259 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33396699 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32261643 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31958786 |
| 64 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30962442 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30435241 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30214102 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27652494 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26596153 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25186280 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24520280 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24494652 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23999198 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22839760 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19698290 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19206512 |
| 76 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18752576 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17937784 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17806621 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16909415 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16022756 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15658404 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15345797 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13116475 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 1.12789467 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12756447 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12398720 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10335258 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09988109 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09836027 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09549552 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09246603 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07989519 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07318144 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07229399 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06903874 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06837470 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06723871 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06723871 |
| 99 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06019704 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05810183 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05810183 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05787013 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05370267 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05280765 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03808307 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03505250 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01515693 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00943280 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00828347 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00550850 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00511186 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99973328 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99161153 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97928792 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96668505 |
| 116 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.96593926 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96260250 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95495205 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94792329 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94787461 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93979583 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92760000 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92352822 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92114704 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 0.91820787 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91745216 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90072368 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89834651 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89328821 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89049082 |
| 131 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.88104333 |
| 132 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86978013 |
| 133 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86472282 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84912339 |
| 135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84436020 |
| 136 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84337824 |
| 137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84312687 |
| 138 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82971590 |
| 139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82960656 |
| 140 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.82831276 |
| 141 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82802047 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82265038 |
| 143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80196703 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79835353 |
| 145 | MYC_22102868_ChIP-Seq_BL_Human | 0.79788256 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79685808 |
| 147 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79472211 |
| 148 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79206938 |
| 149 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79097303 |
| 150 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78462825 |
| 151 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78095318 |
| 152 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78045566 |
| 153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78002782 |
| 154 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77989486 |
| 155 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77812160 |
| 156 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77240702 |
| 157 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74807214 |
| 158 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74807214 |
| 159 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72826607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.42215836 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.47732148 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.27514926 |
| 4 | MP0005365_abnormal_bile_salt | 3.84275829 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.34735731 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.30073326 |
| 7 | MP0009840_abnormal_foam_cell | 2.97939252 |
| 8 | MP0003252_abnormal_bile_duct | 2.93416445 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.91105076 |
| 10 | MP0009785_altered_susceptibility_to | 2.85076344 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.70549827 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.63651227 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.61479933 |
| 14 | MP0005387_immune_system_phenotype | 2.52780473 |
| 15 | MP0001790_abnormal_immune_system | 2.52780473 |
| 16 | MP0005671_abnormal_response_to | 2.52719040 |
| 17 | MP0005025_abnormal_response_to | 2.52589742 |
| 18 | MP0001800_abnormal_humoral_immune | 2.41697758 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.29834333 |
| 20 | MP0002723_abnormal_immune_serum | 2.27994065 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.26296331 |
| 22 | MP0000685_abnormal_immune_system | 2.22552301 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.22166016 |
| 24 | MP0002254_reproductive_system_inflammat | 2.15149419 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.11932240 |
| 26 | MP0010368_abnormal_lymphatic_system | 2.11382903 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.07457454 |
| 28 | MP0001819_abnormal_immune_cell | 2.06410980 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.99887474 |
| 30 | MP0003303_peritoneal_inflammation | 1.96925142 |
| 31 | MP0002405_respiratory_system_inflammati | 1.90595557 |
| 32 | MP0005083_abnormal_biliary_tract | 1.85439147 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.83660913 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.73158837 |
| 35 | MP0006054_spinal_hemorrhage | 1.71653882 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.69480811 |
| 37 | MP0008260_abnormal_autophagy | 1.67860903 |
| 38 | MP0005332_abnormal_amino_acid | 1.65687904 |
| 39 | MP0000609_abnormal_liver_physiology | 1.65602890 |
| 40 | MP0004272_abnormal_basement_membrane | 1.57235947 |
| 41 | MP0003724_increased_susceptibility_to | 1.55371187 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.54544271 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.54127924 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.53352556 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.51788780 |
| 46 | MP0000716_abnormal_immune_system | 1.50201893 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.50054200 |
| 48 | MP0005451_abnormal_body_composition | 1.45190733 |
| 49 | MP0000858_altered_metastatic_potential | 1.44522877 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.43019298 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.42673945 |
| 52 | MP0002398_abnormal_bone_marrow | 1.39703897 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.35087279 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.33486286 |
| 55 | MP0003075_altered_response_to | 1.33431830 |
| 56 | MP0005310_abnormal_salivary_gland | 1.32060105 |
| 57 | MP0003195_calcinosis | 1.29760907 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.29445202 |
| 59 | MP0006082_CNS_inflammation | 1.29192275 |
| 60 | MP0003448_altered_tumor_morphology | 1.28124572 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.28051975 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.27172551 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.26305562 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.26305562 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.26182394 |
| 66 | MP0000604_amyloidosis | 1.25033169 |
| 67 | MP0004130_abnormal_muscle_cell | 1.23657113 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.21643518 |
| 69 | MP0005023_abnormal_wound_healing | 1.19008515 |
| 70 | MP0003436_decreased_susceptibility_to | 1.17445387 |
| 71 | MP0005670_abnormal_white_adipose | 1.17102784 |
| 72 | MP0002132_abnormal_respiratory_system | 1.16182713 |
| 73 | MP0002429_abnormal_blood_cell | 1.15856450 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.15562816 |
| 75 | MP0002722_abnormal_immune_system | 1.15331982 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.14104898 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.12449776 |
| 78 | MP0003690_abnormal_glial_cell | 1.11738560 |
| 79 | MP0001853_heart_inflammation | 1.11357197 |
| 80 | MP0009053_abnormal_anal_canal | 1.10156987 |
| 81 | MP0003866_abnormal_defecation | 1.09598704 |
| 82 | MP0001958_emphysema | 1.09181509 |
| 83 | MP0009764_decreased_sensitivity_to | 1.08712134 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 1.08542953 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.08263832 |
| 86 | MP0008961_abnormal_basal_metabolism | 1.07405569 |
| 87 | MP0000343_altered_response_to | 1.07277632 |
| 88 | MP0005166_decreased_susceptibility_to | 1.06128927 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 1.04871310 |
| 90 | MP0003091_abnormal_cell_migration | 1.04772492 |
| 91 | MP0003828_pulmonary_edema | 1.03076315 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02840935 |
| 93 | MP0009384_cardiac_valve_regurgitation | 1.01056039 |
| 94 | MP0003045_fibrosis | 1.00124873 |
| 95 | MP0004883_abnormal_blood_vessel | 0.99542868 |
| 96 | MP0005390_skeleton_phenotype | 0.99188533 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.99153234 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.98792468 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.98747656 |
| 100 | MP0004947_skin_inflammation | 0.98506877 |
| 101 | MP0002971_abnormal_brown_adipose | 0.97401224 |
| 102 | MP0008469_abnormal_protein_level | 0.95090778 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.94672581 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.94249409 |
| 105 | MP0006138_congestive_heart_failure | 0.93339942 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.93305930 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.92374981 |
| 108 | MP0005164_abnormal_response_to | 0.92342785 |
| 109 | MP0002419_abnormal_innate_immunity | 0.90078341 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.89365918 |
| 111 | MP0000598_abnormal_liver_morphology | 0.88722093 |
| 112 | MP0009278_abnormal_bone_marrow | 0.88476940 |
| 113 | MP0001851_eye_inflammation | 0.87662041 |
| 114 | MP0000249_abnormal_blood_vessel | 0.87148022 |
| 115 | MP0004510_myositis | 0.85501151 |
| 116 | MP0001663_abnormal_digestive_system | 0.85217787 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.83013310 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.82909047 |
| 119 | MP0002006_tumorigenesis | 0.82101915 |
| 120 | MP0004036_abnormal_muscle_relaxation | 0.82024175 |
| 121 | MP0002060_abnormal_skin_morphology | 0.81733757 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 0.80195382 |
| 123 | MP0001873_stomach_inflammation | 0.80186859 |
| 124 | MP0005275_abnormal_skin_tensile | 0.79593381 |
| 125 | MP0001756_abnormal_urination | 0.78105296 |
| 126 | MP0009763_increased_sensitivity_to | 0.77934091 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.76965212 |
| 128 | MP0002972_abnormal_cardiac_muscle | 0.76122301 |
| 129 | MP0008004_abnormal_stomach_pH | 0.75679235 |
| 130 | MP0003795_abnormal_bone_structure | 0.74623421 |
| 131 | MP0000703_abnormal_thymus_morphology | 0.74100832 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.72511081 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.72451264 |
| 134 | MP0003279_aneurysm | 0.70992741 |
| 135 | MP0000371_diluted_coat_color | 0.70601120 |
| 136 | MP0003868_abnormal_feces_composition | 0.70527438 |
| 137 | MP0003950_abnormal_plasma_membrane | 0.70294440 |
| 138 | MP0010630_abnormal_cardiac_muscle | 0.69962491 |
| 139 | MP0000015_abnormal_ear_pigmentation | 0.69797338 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.69475028 |
| 141 | MP0005165_increased_susceptibility_to | 0.68864289 |
| 142 | MP0002933_joint_inflammation | 0.68662532 |
| 143 | MP0001849_ear_inflammation | 0.68570914 |
| 144 | MP0001764_abnormal_homeostasis | 0.68124448 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.68092166 |
| 146 | MP0003329_amyloid_beta_deposits | 0.67314981 |
| 147 | MP0009642_abnormal_blood_homeostasis | 0.67221561 |
| 148 | MP0008874_decreased_physiological_sensi | 0.66810496 |
| 149 | MP0005385_cardiovascular_system_phenoty | 0.64925644 |
| 150 | MP0001544_abnormal_cardiovascular_syste | 0.64925644 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.64697119 |
| 152 | MP0001915_intracranial_hemorrhage | 0.64362754 |
| 153 | MP0002168_other_aberrant_phenotype | 0.62982164 |
| 154 | MP0005375_adipose_tissue_phenotype | 0.61096558 |
| 155 | MP0005076_abnormal_cell_differentiation | 0.59989703 |
| 156 | MP0005330_cardiomyopathy | 0.59340056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.32069409 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.28980493 |
| 3 | Complement deficiency (HP:0004431) | 5.26529755 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.25641469 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.24191950 |
| 6 | Orchitis (HP:0100796) | 5.11561288 |
| 7 | Myositis (HP:0100614) | 5.09350874 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.86159250 |
| 9 | Optic neuritis (HP:0100653) | 4.86159250 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.83087579 |
| 11 | Stomatitis (HP:0010280) | 4.58053157 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.47101311 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.47101311 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.47101311 |
| 15 | Xanthomatosis (HP:0000991) | 4.28508471 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 4.03922401 |
| 17 | Glomerulonephritis (HP:0000099) | 3.96506022 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.94072350 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86665469 |
| 20 | Amelogenesis imperfecta (HP:0000705) | 3.85089195 |
| 21 | Abnormality of complement system (HP:0005339) | 3.70631284 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.62173023 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.58444103 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.55212319 |
| 25 | Recurrent skin infections (HP:0001581) | 3.45256475 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.36893233 |
| 27 | Keratoconjunctivitis (HP:0001096) | 3.34244754 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33726377 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.33577649 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27824241 |
| 31 | Right ventricular cardiomyopathy (HP:0011663) | 3.25751372 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23654790 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19511334 |
| 34 | Obstructive lung disease (HP:0006536) | 3.19511334 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.18810787 |
| 36 | Esophageal varix (HP:0002040) | 3.17053220 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 3.15508386 |
| 38 | Vasculitis (HP:0002633) | 3.09521482 |
| 39 | Meningitis (HP:0001287) | 3.09113206 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08416860 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08416860 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 3.06656123 |
| 43 | Loss of speech (HP:0002371) | 3.06650743 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.06484027 |
| 45 | Polycythemia (HP:0001901) | 3.04959172 |
| 46 | Gingivitis (HP:0000230) | 3.04836361 |
| 47 | Hemoptysis (HP:0002105) | 3.03957889 |
| 48 | Urticaria (HP:0001025) | 3.01791159 |
| 49 | Nephritis (HP:0000123) | 3.00833276 |
| 50 | Encephalitis (HP:0002383) | 3.00699793 |
| 51 | Myocardial infarction (HP:0001658) | 2.95835300 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.92630768 |
| 53 | Hypolipoproteinemia (HP:0010981) | 2.90692051 |
| 54 | T lymphocytopenia (HP:0005403) | 2.90526658 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.89046099 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.86049951 |
| 57 | Hematochezia (HP:0002573) | 2.81227121 |
| 58 | Cerebral aneurysm (HP:0004944) | 2.78137907 |
| 59 | Arterial thrombosis (HP:0004420) | 2.77632622 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.76260360 |
| 61 | Joint hemorrhage (HP:0005261) | 2.76066324 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.72458174 |
| 63 | Chest pain (HP:0100749) | 2.71534513 |
| 64 | Hyperammonemia (HP:0001987) | 2.68756363 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.68275460 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65621050 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65447766 |
| 68 | Epidermoid cyst (HP:0200040) | 2.63858642 |
| 69 | Episodic fever (HP:0001954) | 2.63630552 |
| 70 | Axonal loss (HP:0003447) | 2.63428715 |
| 71 | Fat malabsorption (HP:0002630) | 2.57282770 |
| 72 | Ketosis (HP:0001946) | 2.55053696 |
| 73 | Peritonitis (HP:0002586) | 2.54846342 |
| 74 | Amyloidosis (HP:0011034) | 2.53591354 |
| 75 | Leukocytosis (HP:0001974) | 2.51466197 |
| 76 | Aortic aneurysm (HP:0004942) | 2.51255258 |
| 77 | Increased IgE level (HP:0003212) | 2.51080426 |
| 78 | Recurrent viral infections (HP:0004429) | 2.48108499 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.47056204 |
| 80 | Epistaxis (HP:0000421) | 2.45653886 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.43382897 |
| 82 | Pulmonary embolism (HP:0002204) | 2.42651765 |
| 83 | Anorexia (HP:0002039) | 2.42337855 |
| 84 | Gangrene (HP:0100758) | 2.40995213 |
| 85 | Disinhibition (HP:0000734) | 2.39131050 |
| 86 | Cellulitis (HP:0100658) | 2.34540934 |
| 87 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34124878 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.33775126 |
| 89 | Eczematoid dermatitis (HP:0000976) | 2.31969418 |
| 90 | Spontaneous hematomas (HP:0007420) | 2.30378520 |
| 91 | Mitral stenosis (HP:0001718) | 2.29336696 |
| 92 | Pustule (HP:0200039) | 2.27804551 |
| 93 | Retinal atrophy (HP:0001105) | 2.27340870 |
| 94 | Hypoglycemic coma (HP:0001325) | 2.26447717 |
| 95 | Atrophic scars (HP:0001075) | 2.26147858 |
| 96 | Petechiae (HP:0000967) | 2.25920567 |
| 97 | Vascular calcification (HP:0004934) | 2.25361091 |
| 98 | Hyperglycinuria (HP:0003108) | 2.24118887 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 2.23022191 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.22863494 |
| 101 | Urethral obstruction (HP:0000796) | 2.21801909 |
| 102 | Onycholysis (HP:0001806) | 2.21790332 |
| 103 | Disproportionate tall stature (HP:0001519) | 2.21050047 |
| 104 | Milia (HP:0001056) | 2.20805895 |
| 105 | Skin nodule (HP:0200036) | 2.20459301 |
| 106 | Ketoacidosis (HP:0001993) | 2.20377395 |
| 107 | Abnormality of T cells (HP:0002843) | 2.20235920 |
| 108 | Autoimmune thrombocytopenia (HP:0001973) | 2.19793512 |
| 109 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19445124 |
| 110 | Osteomyelitis (HP:0002754) | 2.18606856 |
| 111 | Abnormality of the pleura (HP:0002103) | 2.16903344 |
| 112 | Cardiovascular calcification (HP:0011915) | 2.15890216 |
| 113 | Increased IgM level (HP:0003496) | 2.15772376 |
| 114 | Gout (HP:0001997) | 2.14347839 |
| 115 | Malnutrition (HP:0004395) | 2.12182341 |
| 116 | Ventricular tachycardia (HP:0004756) | 2.07667968 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 2.07321531 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07098321 |
| 119 | Mucopolysacchariduria (HP:0008155) | 2.07098321 |
| 120 | Cholelithiasis (HP:0001081) | 2.06449734 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 2.05675349 |
| 122 | Increased serum ferritin (HP:0003281) | 2.05378470 |
| 123 | Aneurysm (HP:0002617) | 2.04231768 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 2.01796646 |
| 125 | Hydroxyprolinuria (HP:0003080) | 2.00727084 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 2.00727084 |
| 127 | Glomerulopathy (HP:0100820) | 2.00691021 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00501226 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00501226 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00501226 |
| 131 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00081859 |
| 132 | Abnormality of the pericardium (HP:0001697) | 1.99955547 |
| 133 | Polyneuropathy (HP:0001271) | 1.99719555 |
| 134 | Arterial tortuosity (HP:0005116) | 1.99037854 |
| 135 | Vertigo (HP:0002321) | 1.98748953 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.98579705 |
| 137 | Hyperglycinemia (HP:0002154) | 1.97902560 |
| 138 | Abnormality of the endocardium (HP:0004306) | 1.97317455 |
| 139 | Abnormality of glycine metabolism (HP:0010895) | 1.95573288 |
| 140 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95573288 |
| 141 | Striae distensae (HP:0001065) | 1.95444016 |
| 142 | Increased CSF protein (HP:0002922) | 1.95029643 |
| 143 | Abnormality of methionine metabolism (HP:0010901) | 1.94292836 |
| 144 | Increased cerebral lipofuscin (HP:0011813) | 1.93632921 |
| 145 | Purpura (HP:0000979) | 1.93342993 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.93256641 |
| 147 | Cholecystitis (HP:0001082) | 1.91899119 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 1.91899119 |
| 149 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90756490 |
| 150 | Keratitis (HP:0000491) | 1.90169036 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.89564652 |
| 152 | Hepatosplenomegaly (HP:0001433) | 1.89349712 |
| 153 | Inflammation of the large intestine (HP:0002037) | 1.88271175 |
| 154 | Impaired platelet aggregation (HP:0003540) | 1.88069946 |
| 155 | Abnormal platelet function (HP:0011869) | 1.88069946 |
| 156 | Abnormality of T cell physiology (HP:0011840) | 1.86837995 |
| 157 | Reticulocytosis (HP:0001923) | 1.86635149 |
| 158 | Granulocytopenia (HP:0001913) | 1.86473473 |
| 159 | Gingival bleeding (HP:0000225) | 1.85857883 |
| 160 | Hypergammaglobulinemia (HP:0010702) | 1.85442984 |
| 161 | Vascular tortuosity (HP:0004948) | 1.85077393 |
| 162 | Mitral valve prolapse (HP:0001634) | 1.84886092 |
| 163 | Peripheral demyelination (HP:0011096) | 1.84663026 |
| 164 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84284687 |
| 165 | Abnormality of the peritoneum (HP:0002585) | 1.83908669 |
| 166 | Hyporeflexia of lower limbs (HP:0002600) | 1.83825518 |
| 167 | Eosinophilia (HP:0001880) | 1.83416007 |
| 168 | Acne (HP:0001061) | 1.83244374 |
| 169 | Mutism (HP:0002300) | 1.82479756 |
| 170 | Dysostosis multiplex (HP:0000943) | 1.80513552 |
| 171 | Premature loss of primary teeth (HP:0006323) | 1.79047569 |
| 172 | Cheilitis (HP:0100825) | 1.78742880 |
| 173 | Neurofibrillary tangles (HP:0002185) | 1.78707368 |
| 174 | Recurrent pneumonia (HP:0006532) | 1.78658581 |
| 175 | Spondylolisthesis (HP:0003302) | 1.78079847 |
| 176 | Hyperglycemia (HP:0003074) | 1.77475641 |
| 177 | Stroke (HP:0001297) | 1.76626479 |
| 178 | Hepatocellular carcinoma (HP:0001402) | 1.76467594 |
| 179 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75471418 |
| 180 | Metabolic acidosis (HP:0001942) | 1.74289693 |
| 181 | Aortic dissection (HP:0002647) | 1.74231526 |
| 182 | Hyperbilirubinemia (HP:0002904) | 1.74020135 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.73549777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.96954262 |
| 2 | ERN1 | 3.46934262 |
| 3 | BLK | 3.40762411 |
| 4 | RIPK1 | 3.18598924 |
| 5 | TIE1 | 2.37997980 |
| 6 | IRAK3 | 2.23555766 |
| 7 | MAP3K3 | 2.17481147 |
| 8 | FGFR4 | 2.15749242 |
| 9 | SIK1 | 2.12519875 |
| 10 | EPHB1 | 2.10530527 |
| 11 | MAPK15 | 2.05199975 |
| 12 | KDR | 1.92985276 |
| 13 | FES | 1.85184248 |
| 14 | LATS1 | 1.81798794 |
| 15 | TRIB3 | 1.80603062 |
| 16 | AKT3 | 1.79482067 |
| 17 | TXK | 1.77864122 |
| 18 | PTK6 | 1.75281650 |
| 19 | CAMK1D | 1.68248414 |
| 20 | DAPK2 | 1.66177836 |
| 21 | PDK2 | 1.56340273 |
| 22 | PRPF4B | 1.53792169 |
| 23 | PKN2 | 1.53748576 |
| 24 | BMPR2 | 1.49456084 |
| 25 | MAP2K3 | 1.49001698 |
| 26 | SYK | 1.45651578 |
| 27 | CAMK1G | 1.44608878 |
| 28 | TTN | 1.40256847 |
| 29 | TNK2 | 1.40099852 |
| 30 | PDGFRA | 1.38938398 |
| 31 | TBK1 | 1.38879525 |
| 32 | TRPM7 | 1.36258585 |
| 33 | PTK2 | 1.34709747 |
| 34 | IRAK1 | 1.33349942 |
| 35 | PAK4 | 1.28245335 |
| 36 | BTK | 1.27977598 |
| 37 | YES1 | 1.23853637 |
| 38 | ACVR1B | 1.21787557 |
| 39 | TAOK1 | 1.21232963 |
| 40 | PTK2B | 1.20810475 |
| 41 | LYN | 1.20404154 |
| 42 | TYK2 | 1.19674032 |
| 43 | STK10 | 1.19444684 |
| 44 | IKBKB | 1.17976637 |
| 45 | CSK | 1.17201284 |
| 46 | KIT | 1.13073477 |
| 47 | SIK3 | 1.11387263 |
| 48 | MAPK12 | 1.06472704 |
| 49 | SGK3 | 1.06213651 |
| 50 | FRK | 1.05523924 |
| 51 | IRAK2 | 1.05270535 |
| 52 | TAOK2 | 1.04884290 |
| 53 | INSRR | 0.99492239 |
| 54 | JAK1 | 0.99479698 |
| 55 | CDC42BPA | 0.98504989 |
| 56 | MARK3 | 0.98238599 |
| 57 | LCK | 0.97931506 |
| 58 | MATK | 0.95677623 |
| 59 | BCKDK | 0.94539107 |
| 60 | FGFR3 | 0.94426225 |
| 61 | MYLK | 0.93847611 |
| 62 | FER | 0.92591587 |
| 63 | EPHA2 | 0.92096298 |
| 64 | DDR2 | 0.89654650 |
| 65 | CASK | 0.87634271 |
| 66 | MST1R | 0.86797003 |
| 67 | DMPK | 0.85784045 |
| 68 | PDGFRB | 0.83995953 |
| 69 | SIK2 | 0.83650740 |
| 70 | JAK2 | 0.82350170 |
| 71 | MAP3K14 | 0.82345082 |
| 72 | MAP3K5 | 0.82271997 |
| 73 | ICK | 0.81773132 |
| 74 | TEC | 0.81528038 |
| 75 | STK24 | 0.81476155 |
| 76 | MAP3K7 | 0.81253799 |
| 77 | MAPK7 | 0.79932129 |
| 78 | ZAP70 | 0.79872415 |
| 79 | RIPK4 | 0.79777301 |
| 80 | PDPK1 | 0.79398327 |
| 81 | MAP3K13 | 0.78704911 |
| 82 | ITK | 0.77469378 |
| 83 | ERBB2 | 0.76145293 |
| 84 | RET | 0.76092351 |
| 85 | MAP3K1 | 0.75914124 |
| 86 | EPHB2 | 0.75843795 |
| 87 | FGFR2 | 0.75231216 |
| 88 | MOS | 0.72673735 |
| 89 | CAMKK2 | 0.71510653 |
| 90 | MAP3K2 | 0.71473838 |
| 91 | PRKAA2 | 0.71196110 |
| 92 | MARK2 | 0.69761331 |
| 93 | CSF1R | 0.69593363 |
| 94 | STK3 | 0.69230445 |
| 95 | IRAK4 | 0.68617206 |
| 96 | TAOK3 | 0.68147279 |
| 97 | EPHA3 | 0.67952535 |
| 98 | SGK2 | 0.67923349 |
| 99 | PIK3CG | 0.67826315 |
| 100 | IKBKE | 0.67423376 |
| 101 | MAP2K4 | 0.66356353 |
| 102 | PIK3CA | 0.65029282 |
| 103 | PRKD2 | 0.63323006 |
| 104 | MET | 0.62393643 |
| 105 | KSR2 | 0.62341817 |
| 106 | EGFR | 0.61938432 |
| 107 | LMTK2 | 0.61626424 |
| 108 | NLK | 0.61260882 |
| 109 | PRKD1 | 0.60278792 |
| 110 | CHUK | 0.59533289 |
| 111 | GRK6 | 0.59050500 |
| 112 | HCK | 0.58106302 |
| 113 | MAP3K11 | 0.57318910 |
| 114 | WNK1 | 0.57259688 |
| 115 | GSK3A | 0.56125927 |
| 116 | STK38 | 0.55142657 |
| 117 | KSR1 | 0.54675827 |
| 118 | MAP2K6 | 0.54297981 |
| 119 | IGF1R | 0.54282228 |
| 120 | PRKG2 | 0.53543407 |
| 121 | MAP3K10 | 0.53154569 |
| 122 | FGR | 0.52693101 |
| 123 | NEK9 | 0.51346928 |
| 124 | PRKCH | 0.51144151 |
| 125 | MAP3K6 | 0.51060283 |
| 126 | CDK6 | 0.49792144 |
| 127 | FYN | 0.49242217 |
| 128 | GRK7 | 0.48286583 |
| 129 | PDK1 | 0.47926969 |
| 130 | ERBB4 | 0.46878834 |
| 131 | MAP4K1 | 0.46864219 |
| 132 | LRRK2 | 0.45783718 |
| 133 | BMX | 0.45290318 |
| 134 | MTOR | 0.44833766 |
| 135 | PAK2 | 0.44444451 |
| 136 | PDK3 | 0.44046522 |
| 137 | PDK4 | 0.44046522 |
| 138 | JAK3 | 0.43578393 |
| 139 | ADRBK2 | 0.42816194 |
| 140 | PRKCQ | 0.41825234 |
| 141 | HIPK2 | 0.39314313 |
| 142 | MAP3K8 | 0.39194934 |
| 143 | ABL1 | 0.38104739 |
| 144 | CLK1 | 0.35237662 |
| 145 | MAPKAPK2 | 0.31266968 |
| 146 | PIM1 | 0.30939034 |
| 147 | MELK | 0.29666711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.01489093 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.87812061 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81237396 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77956846 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.66881185 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55258774 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48674009 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18696050 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14035668 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.10573054 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06713504 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.05174716 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.04609316 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00395820 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90800152 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82249110 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81505521 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79921427 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78464146 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77351084 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.76851209 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74231356 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71991555 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70688601 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68601057 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68192120 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60823191 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.58085919 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.57953984 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55535710 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.55137009 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54757758 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49021503 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.46106080 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44938765 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44611199 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.44370669 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44143013 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40324812 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36219679 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34813847 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33937193 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33855847 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33604591 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30808675 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30180682 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26880973 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26589917 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26508253 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26327241 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26192614 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26138611 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.25117806 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22078104 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19813580 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19692852 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.19554253 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18787436 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18434772 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 1.18319474 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 1.17659059 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15152461 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13966384 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13593096 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.09615266 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09545157 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09119117 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06133190 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05657365 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04866516 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 1.03458859 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03136944 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.96367592 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.94310749 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91795192 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91185616 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86783977 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86350126 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85071108 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83700643 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.83620654 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.83148668 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.82217292 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81707715 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80917032 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79193777 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78115000 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77414300 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76844514 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.75862992 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75644891 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73604672 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73380790 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72929051 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72836210 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70342755 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69671046 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69362212 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68748587 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68360224 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67059224 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.66944709 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65812651 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.65787397 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64387111 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63761925 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61324082 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60622346 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60582971 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60341210 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59851581 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59654556 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.58528695 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58424551 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58312312 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57047269 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56869453 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.56547932 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.54602836 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53954142 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52048025 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.51978881 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.51634415 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50713448 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49220940 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48533094 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47971274 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46884109 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46491677 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44056855 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43767611 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42760966 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41366042 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41097660 |
| 135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40105047 |
| 136 | * Notch signaling pathway_Homo sapiens_hsa04330 | 0.40005944 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39902301 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39382412 |
| 139 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39337806 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39267363 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39209937 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39205823 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38396969 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37767385 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36803796 |
| 146 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36787444 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36766971 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36267683 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35746061 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35450445 |
| 151 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35286688 |
| 152 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34163806 |
| 153 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34002848 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33803192 |
| 155 | Prostate cancer_Homo sapiens_hsa05215 | 0.33441822 |
| 156 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33141051 |
| 157 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32840391 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32737276 |
| 159 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32718563 |
| 160 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32093263 |
| 161 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31738314 |
| 162 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30924303 |
| 163 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30028043 |
| 164 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29881913 |
| 165 | Tuberculosis_Homo sapiens_hsa05152 | 0.28556891 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27394106 |
| 167 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.27282955 |
| 168 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27190169 |
| 169 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26884681 |
| 170 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26719432 |

